Smyth EC - Search Results

1

Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer.

Pietrantonio F, Miceli R, Raimondi A, Kim YW, Kang WK, Langley RE, Choi YY, Kim KM, Nankivell MG, Morano F, Wotherspoon A, Valeri N, Kook MC, An JY, Grabsch HI, Fucà G, Noh SH, Sohn TS, Kim S, Di Bartolomeo M, Cunningham D, Lee J, Cheong JH, Smyth EC. Pietrantonio F, et al. Among authors: smyth ec. J Clin Oncol. 2019 Dec 10;37(35):3392-3400. doi: 10.1200/JCO.19.01124. Epub 2019 Sep 12. J Clin Oncol. 2019. PMID: 31513484 Free article.

2

Targeted therapy for gastric cancer.

Smyth EC, Cunningham D. Smyth EC, et al. Curr Treat Options Oncol. 2012 Sep;13(3):377-89. doi: 10.1007/s11864-012-0192-6. Curr Treat Options Oncol. 2012. PMID: 22552927 Review.

3

Gastric cancer in 2012: Defining treatment standards and novel insights into disease biology.

Smyth EC, Cunningham D. Smyth EC, et al. Nat Rev Clin Oncol. 2013 Feb;10(2):73-4. doi: 10.1038/nrclinonc.2012.228. Epub 2013 Jan 8. Nat Rev Clin Oncol. 2013. PMID: 23296114 Review. No abstract available.

4

The role of personalized medicine in metastatic colorectal cancer: an evolving landscape.

Moorcraft SY, Smyth EC, Cunningham D. Moorcraft SY, et al. Among authors: smyth ec. Therap Adv Gastroenterol. 2013 Sep;6(5):381-95. doi: 10.1177/1756283X13491797. Therap Adv Gastroenterol. 2013. PMID: 24003339 Free PMC article.

5

Adjuvant or neoadjuvant therapy for operable esophagogastric cancer?

Moorcraft SY, Smyth EC, Cunningham D. Moorcraft SY, et al. Among authors: smyth ec. Gastric Cancer. 2015 Jan;18(1):1-10. doi: 10.1007/s10120-014-0356-0. Epub 2014 Mar 18. Gastric Cancer. 2015. PMID: 24638977 Review.

6

Operable gastro-oesophageal junctional adenocarcinoma: Where to next?

Smyth EC, Cunningham D. Smyth EC, et al. World J Gastrointest Oncol. 2014 Jun 15;6(6):145-55. doi: 10.4251/wjgo.v6.i6.145. World J Gastrointest Oncol. 2014. PMID: 24936225 Free PMC article. Review.

7

Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors.

Smyth EC, Sclafani F, Cunningham D. Smyth EC, et al. Onco Targets Ther. 2014 Jun 12;7:1001-14. doi: 10.2147/OTT.S44941. eCollection 2014. Onco Targets Ther. 2014. PMID: 24959087 Free PMC article. Review.

8

Optimal management of esophageal adenocarcinoma: should we be CROSS?

Smyth EC, Waddell TS, Cunningham D. Smyth EC, et al. J Clin Oncol. 2014 Sep 20;32(27):3080-1. doi: 10.1200/JCO.2014.55.5243. Epub 2014 Jul 28. J Clin Oncol. 2014. PMID: 25071100 No abstract available.

9

Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.

Davies AR, Gossage JA, Zylstra J, Mattsson F, Lagergren J, Maisey N, Smyth EC, Cunningham D, Allum WH, Mason RC. Davies AR, et al. Among authors: smyth ec. J Clin Oncol. 2014 Sep 20;32(27):2983-90. doi: 10.1200/JCO.2014.55.9070. J Clin Oncol. 2014. PMID: 25071104

10

Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients.

Formica V, Luccchetti J, Cunningham D, Smyth EC, Ferroni P, Nardecchia A, Tesauro M, Cereda V, Guadagni F, Roselli M. Formica V, et al. Among authors: smyth ec. Med Oncol. 2014 Sep;31(9):166. doi: 10.1007/s12032-014-0166-6. Epub 2014 Aug 23. Med Oncol. 2014. PMID: 25148896

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page